ASX - By Stock
|
SPL |
Re:
Starpharma's website has been updated
|
|
SCBystander
|
23 |
5.3K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
23
|
5.3K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: S&P DJI Announces March 2024 Quarterly Rebalance
|
|
SCBystander
|
27 |
6.2K |
3 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
27
|
6.2K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Has the seling dried up
|
|
SCBystander
|
72 |
13K |
0 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
72
|
13K
|
0
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
SCBystander
|
153 |
42K |
5 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
153
|
42K
|
5
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
SCBystander
|
153 |
42K |
15 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
153
|
42K
|
15
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4D and Half Year Accounts
|
|
SCBystander
|
25 |
7.3K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
25
|
7.3K
|
1
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
SCBystander
|
153 |
42K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
153
|
42K
|
4
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
SCBystander
|
153 |
42K |
5 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
153
|
42K
|
5
|
|
Charts
|
IPD |
Re:
IPD chart
|
|
SCBystander
|
816 |
342K |
2 |
27/02/24 |
27/02/24 |
Charts
|
816
|
342K
|
2
|
|
Charts
|
IPD |
Re:
IPD chart
|
|
SCBystander
|
816 |
342K |
6 |
27/02/24 |
27/02/24 |
Charts
|
816
|
342K
|
6
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
SCBystander
|
153 |
42K |
21 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
153
|
42K
|
21
|
|
ASX - By Stock
|
SPL Medicine |
Re:
TGA STAFF SICK - Delayed Interim decision re Scheduling Astodrimer sodium as Nasal Spray
|
|
SCBystander
|
8 |
2.3K |
1 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
8
|
2.3K
|
1
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Appointment of Chair
|
|
SCBystander
|
5 |
1.3K |
6 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
5
|
1.3K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Time for an HONEST update
|
|
SCBystander
|
3 |
1.1K |
4 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
3
|
1.1K
|
4
|
|
ASX - By Stock
|
SLC |
Re:
Ann: ABB: Non-Binding Indicative Offer for Superloop
|
|
SCBystander
|
43 |
16K |
2 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
43
|
16K
|
2
|
|
ASX - By Stock
|
SLC |
Re:
Ann: ABB: Non-Binding Indicative Offer for Superloop
|
|
SCBystander
|
43 |
16K |
2 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
43
|
16K
|
2
|
|
ASX - By Stock
|
ABB |
Re:
Ann: Non-Binding Indicative Offer for Superloop
|
|
SCBystander
|
17 |
7.4K |
4 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
17
|
7.4K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Letter from Cheryl..
|
|
SCBystander
|
72 |
16K |
2 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
72
|
16K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Letter from Cheryl..
|
|
SCBystander
|
72 |
16K |
2 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
72
|
16K
|
2
|
|
Charts
|
IPD |
Re:
IPD chart
|
|
SCBystander
|
816 |
342K |
4 |
20/02/24 |
20/02/24 |
Charts
|
816
|
342K
|
4
|
|
ASX - By Stock
|
ALC |
Re:
Webcast Recording - Business Update Q2 FY2024
|
|
SCBystander
|
20 |
6.9K |
1 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
20
|
6.9K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Sell something maybe the lot
|
|
SCBystander
|
2 |
678 |
2 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
2
|
678
|
2
|
|
Charts
|
IPD |
Re:
IPD chart
|
|
SCBystander
|
816 |
342K |
4 |
19/02/24 |
19/02/24 |
Charts
|
816
|
342K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Covid-19 is not over by a long shot ladies and gentlemen
|
|
SCBystander
|
102 |
21K |
1 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
102
|
21K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV US FDA Appeal Outcome
|
|
SCBystander
|
60 |
13K |
9 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
60
|
13K
|
9
|
|
ASX - By Stock
|
OSL Biotech |
Re:
Time to go long big on $OSL?
|
|
SCBystander
|
17 |
7.1K |
4 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
17
|
7.1K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Covid-19 is not over by a long shot ladies and gentlemen
|
|
SCBystander
|
102 |
21K |
6 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
102
|
21K
|
6
|
|
ASX - By Stock
|
IPD |
Re:
Time for the Board and Management to Buy On Market
|
|
SCBystander
|
8 |
2.6K |
7 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
8
|
2.6K
|
7
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
|
|
SCBystander
|
280 |
59K |
6 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
280
|
59K
|
6
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
SCBystander
|
8 |
2.2K |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
8
|
2.2K
|
1
|
|
ASX - By Stock
|
MX1 |
Re:
Ann: MX1 - Quarterly Cashflows and Activity Statement
|
|
SCBystander
|
6 |
2.7K |
4 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
6
|
2.7K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Quarterly Activities Report and Appendix 4C - Dec23
|
|
SCBystander
|
5 |
2.1K |
0 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
5
|
2.1K
|
0
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
SCBystander
|
2 |
1.3K |
3 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
2
|
1.3K
|
3
|
|
ASX - By Stock
|
OSL |
Re:
OncoSil Insurance Adoption
|
|
SCBystander
|
67 |
23K |
0 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
67
|
23K
|
0
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Notification of Results Release Dates and Conference Call
|
|
SCBystander
|
31 |
7.6K |
4 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
31
|
7.6K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
DEP Deals
|
|
SCBystander
|
6 |
1.4K |
1 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
6
|
1.4K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV sales and distribution agreement MENA region
|
|
SCBystander
|
37 |
8.2K |
3 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
37
|
8.2K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel BV sales and distribution agreement MENA region
|
|
SCBystander
|
37 |
8.2K |
1 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
37
|
8.2K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Appendix 3X - Cheryl Maley
|
|
SCBystander
|
3 |
978 |
0 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
3
|
978
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Keeping shareholders in the loop
|
|
SCBystander
|
46 |
9.6K |
2 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
46
|
9.6K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive DEP docetaxel Phase 2 results
|
|
SCBystander
|
131 |
27K |
1 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
131
|
27K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Positive DEP docetaxel Phase 2 results
|
|
SCBystander
|
131 |
27K |
15 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
131
|
27K
|
15
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Strategy & Market Update
|
|
SCBystander
|
20 |
12K |
1 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
20
|
12K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Receipt of Notice under Section 249D of the Corporations Act
|
|
SCBystander
|
11 |
5.6K |
0 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
11
|
5.6K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
AGM 2023 & Resolutions
|
|
SCBystander
|
17 |
7.0K |
0 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
17
|
7.0K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Information For Retail Shareholders
|
|
SCBystander
|
541 |
114K |
5 |
10/12/23 |
10/12/23 |
ASX - By Stock
|
541
|
114K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Institutional Allocation
|
|
SCBystander
|
263 |
68K |
3 |
10/12/23 |
10/12/23 |
ASX - By Stock
|
263
|
68K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Launches Entitlement Offer and Placement
|
|
SCBystander
|
166 |
50K |
0 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
166
|
50K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Launches Entitlement Offer and Placement
|
|
SCBystander
|
166 |
50K |
1 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
166
|
50K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
SCBystander
|
716 |
198K |
2 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
716
|
198K
|
2
|
|